|
Jun 20
|
Vaxxinity UB-312 Parkinson’s Trial Results Published in Nature Medicine
|
|
Jan 30
|
Vaxxinity, UF Join Forces Against Neurodegenerative Diseases
|
|
Jan 30
|
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida
|
|
Jul 17
|
Promising Milestone in Neurodegenerative Disease Treatment: Vaxxinity’s UB-312 in Parkinson’s Patients
|
|
Jul 17
|
Vaxxinity Demonstrates Target Engagement of Toxic Alpha-Synuclein in Parkinson’s Patients
|